Document Detail


Alopecia and mood stabilizers: two case reports.
MedLine Citation:
PMID:  1486112     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two cases of alopecia observed during treatment with lithium and valproate are described, and the recent literature on this subject is reviewed. Our clinical observations confirm earlier reports. These toxic alopecias are characterized by a diffuse but rarely total hair loss. After stopping medication, the hair grows back generally and completely. Two cases of toxic alopecia are presented where hair grew back following a substitution of lithium by valproate in the first case and after stopping valproate in the second. The evaluation and therapeutic attitude in the presence of alopecia in patients needing mood stabilizers are also discussed.
Authors:
C Uehlinger; L Barrelet; M Touabi; P Baumann
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  European archives of psychiatry and clinical neuroscience     Volume:  242     ISSN:  0940-1334     ISO Abbreviation:  Eur Arch Psychiatry Clin Neurosci     Publication Date:  1992  
Date Detail:
Created Date:  1993-02-25     Completed Date:  1993-02-25     Revised Date:  2009-05-11    
Medline Journal Info:
Nlm Unique ID:  9103030     Medline TA:  Eur Arch Psychiatry Clin Neurosci     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  85-8     Citation Subset:  IM    
Affiliation:
Hôpital Psychiatrique Cantona, Perreux/Neuchätel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Alopecia / chemically induced*
Carbamazepine / adverse effects*,  therapeutic use
Clorazepate Dipotassium / administration & dosage,  therapeutic use
Depressive Disorder / drug therapy*,  rehabilitation
Female
Fluvoxamine / administration & dosage,  therapeutic use
Haloperidol / administration & dosage,  therapeutic use
Hospitalization
Humans
Lithium Carbonate / adverse effects*,  blood,  therapeutic use
Methotrimeprazine / administration & dosage,  therapeutic use
Middle Aged
Schizophrenia / drug therapy*,  rehabilitation
Valproic Acid / adverse effects*,  therapeutic use
Chemical
Reg. No./Substance:
298-46-4/Carbamazepine; 52-86-8/Haloperidol; 54739-18-3/Fluvoxamine; 554-13-2/Lithium Carbonate; 57109-90-7/Clorazepate Dipotassium; 60-99-1/Methotrimeprazine; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acceptance, attrition, and outcome in an outpatient treatment programme for alcoholics. A comparison...
Next Document:  The risk of minor depression in families of probands with major depression: sex differences and fami...